Theory and efficacy of stem cells from different sources in the treatment of diabetic foot
10.3969/j.issn.2095-4344.2015.41.028
- VernacularTitle:不同来源干细胞治疗糖尿病性足病的原理与效果比较
- Author:
Gaoyang CHEN
;
Fei CHANG
;
Rui LI
;
Hanyang ZHANG
;
Quanyu DONG
;
Zhende JIANG
;
Maosheng LIU
- Publication Type:Journal Article
- Keywords:
Diabetic Foot;
Cytokines;
Mesenchymal Stem Cels;
Monocytes;
Tissue Engineering
- From:
Chinese Journal of Tissue Engineering Research
2015;(41):6718-6724
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Stem cel is a kind of pluripotent cels with self-replication ability, which can differentiate into various cels under certain conditions. Furthermore, stem cels are rich in a variety of growth factors, which can induce the generation of vessels and nerves, and improve the blood supply of lower limbs, thereby achieving the treatment and preventions of lower limb ischemia OBJECTIVE:To summarize and compare the recent achievements in the theory and therapeutic efficacy of stem cels from different sources in the treatment of diabetic foot. METHODS:The first and second authors retrieved PubMed, Sciencedirect and Medline databases for relevant articles published from January 2000 to January 2015. The key words were “diabetic foot, pathogenesis, stem cel therapy” in English. Initialy, 186 articles were retrieved, and finaly 44 articles were included in result analysis. RESULTS AND CONCLUSION:Stem cels can be a new choice for the treatment of diabetic foot. After stem cel therapy, corresponding symptoms have been aleviated, including the generation of new blood vessels and the reshaping of the colateral vessels, the improvement of motor nerve conduction velocity and nerve reflex, the improvement of the sense of skin pain and temperature, and pain relief. It is stil unclear whether alogeneic stem cels are safe or not, but autologous stem cels, especialy bone marrow mesenchymal stem cels, can be better able to repair damaged vessels and nerves and restore the microcirculation of blood supply. Currently, we need to do more basic and clinical researches to solve the folowing problems: to confirm the effectiveness and safety of stem cel therapy for diabetic foot; to identify whether there is a difference in the differentiation and secretory activity between stem cels in diabetic patients and ordinary people; to give ful play to the treatment of diabetic foot.
